Best of June: Top 5 Insights In Clinical Trial Technology

#1 - How Is RIM Software Transforming Regulatory Compliance?

Medical device and pharma companies are increasingly turning to Regulatory Information Management (RIM) software solutions to streamline regulatory processes, enhance compliance, and improve efficiency. This article explores RIM software tools and their role in overcoming regulatory challenges.

#2 - The Future Of AI In Clinical Research, Delivered Today

AI and computational modeling will transform life sciences into a golden age of advanced interdisciplinary research and development between biologists, data scientists, and engineers. But with this opportunity comes the need for transparency. To build trust and ensure responsible AI use, organizations must adopt clear, risk-based frameworks.

#3 - Integrating QMS And eTMF For Proactive Clinical Trial Quality

In today’s clinical trial landscape, where complexity is the new challenge, integration is not optional: QMS defines quality, and eTMF proves it. Learn how by aligning processes, documentation, and oversight, we can create clinical trial ecosystems that are compliant by design, not by audit.

#4 - Clinical Trials In The Age Of Cost Caps: Navigating The NIH 15% Rule

On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants. This change is expected to reshape the clinical research landscape—particularly for CROs, research sites, and academic institutions at the core of clinical trial execution.

#5 - What Sponsors Should Know About The Remote Patient Monitoring (RPM) Market

The remote patient monitoring market is expected to grow from $27.72 billion in 2024 to $56.94 billion by 2030, at a CAGR of 12.7% during the forecast period, according to MarketsandMarkets™. Learn more about its outlook.